---
title: Quick Reference Cards – rTKA Anesthesia Pathways
version: 1.4
last-updated: 2025-12-14
---

# Quick Reference Cards  
Robot-Assisted Total Knee Arthroplasty (rTKA) – 2025  
**Print → laminate → place at anesthesia machine**

> **Educational Use Only (Non-Clinical Use).** This card is an educational synthesis and **not** a guideline, order set, or medical advice. Dosing and agent selection must be individualized to patient physiology, comorbidities, monitoring strategy, and institutional policy under **supervision of a licensed attending anesthesiologist**. Do not use this material to provide patient care.

---

## Ketamine Guardrails (Patient Selection, Hemodynamics, and BIS/EEG)

Ketamine is presented here as an **optional sub-anesthetic adjunct** for opioid-sparing analgesia (not a default primary induction agent). Effects are **context-dependent**.

**Use caution, reduce dose, or omit** ketamine bolus/infusion when any of the following are present (non-exhaustive):
- **Hemodynamic instability** or escalating vasopressor requirement; suspected **catecholamine-depleted physiology**
- **Frailty / advanced age** (limited physiologic reserve; higher ASA class) where hypotension/delirium/prolonged recovery risk is elevated
- Clinically significant **tachyarrhythmia risk** or contexts where sympathetic stimulation may be undesirable
- Severe psychiatric disease with active psychosis (context-dependent)

**Depth monitoring caveat (BIS/EEG):** Ketamine can **increase BIS** and alter EEG-derived indices in ways that may not reflect inadequate hypnosis. Avoid titrating hypnotics solely to BIS values after ketamine; correlate with clinical context and, when available, raw EEG trends.

---

# Pathway 1 — OFIA + ACB/IPACK (Preferred ERAS Pathway)

| Section | Quick Reference |
|--------|-----------------|
| **Pre-op** | • Acetaminophen **1 g PO**<br>• Celecoxib **400 mg PO** (or meloxicam 15 mg)<br>• Dexamethasone **8–10 mg IV**<br>• Scopolamine patch (high PONV risk)<br>• **Avoid gabapentinoids** |
| **Blocks (Pre-Induction)** | • **Midazolam 1–2 mg IV** (anxiolysis; **dose-reduce in elderly/frail**)<br>• **ACB:** 20–30 mL ropivacaine 0.2–0.25%<br>• **IPACK:** 20 mL ropivacaine 0.2–0.25%<br>• Max ropivacaine dose: **~3 mg/kg** (≈210 mg for 70 kg)<br>• **Lipid emulsion 20% available** (LAST preparedness) |
| **Induction** | • Midazolam **0.5–1 mg IV** (optional; dose-reduce in elderly/frail)<br>• Propofol **1.5–2 mg/kg** (primary hypnotic)<br>• Ketamine **0.2–0.5 mg/kg IV** **optional adjunct**, titrate to effect (see guardrails)<br>• Rocuronium **0.6–1.0 mg/kg** |
| **Adjuncts** | • Magnesium **30–50 mg/kg IV** over 15–20 min (**avoid CrCl <30 mL/min**)<br>• Dexmedetomidine **0.2–0.7 mcg/kg/hr** (0.2–0.6 if elderly/frail; **avoid large bolus loading in fragile patients**)<br>• Ketamine infusion **0.1–0.2 mg/kg/hr** **optional**, selection-dependent |
| **Maintenance** | • **Sevoflurane 0.8–1.2 MAC** OR **Propofol TIVA 75–150 mcg/kg/min**<br>• Maintain **MAP ≥65 mmHg** (individualize for CAD/cerebrovascular disease)<br>• Phenylephrine 50–100 mcg IV (HR >70); ephedrine 5–10 mg IV (HR <60) per institutional practice |
| **Emergence** | • Stop dexmedetomidine **10–15 min** before extubation (as tolerated)<br>• Stop ketamine at closure (if used)<br>• Ondansetron **4 mg IV**<br>• Sugammadex **2 mg/kg** (TOF ≥2) or **4 mg/kg** (deep block) |
| **PACU** | • Expected pain **0–3/10**<br>• Ketamine rescue **0.1–0.15 mg/kg IV q10–15 min** (max 3 doses) **when appropriate**<br>• Escalate to opioids **only if inadequate** |

---

# Pathway 2 — OFIA Block-Free (No ACB/IPACK)

| Section | Quick Reference |
|--------|-----------------|
| **Pre-op** | Same as Pathway 1 (acetaminophen, NSAID, dexamethasone, scopolamine). |
| **Blocks** | None – document reason (**anticoagulation, refusal, anatomy, workflow**).<br>**Surgeon infiltration:** 100–150 mL ropivacaine 0.2% (max dose **~3 mg/kg**). |
| **Induction** | • Midazolam **1–2 mg IV** (dose-reduce in elderly/frail)<br>• Propofol **1.5–2 mg/kg** (primary hypnotic)<br>• Ketamine **0.2–0.5 mg/kg IV** **optional adjunct**, titrate to effect (see guardrails)<br>• Rocuronium **0.6–1.0 mg/kg** |
| **Adjuncts / Maintenance** | • Magnesium **30–50 mg/kg** (avoid CrCl <30)<br>• Dexmedetomidine **0.3–0.7 mcg/kg/hr** (0.2–0.6 if elderly/frail; avoid large bolus loading in fragile patients)<br>• **Sevoflurane 0.8–1.2 MAC** OR **Propofol TIVA 75–150 mcg/kg/min**<br>• Ketamine infusion **0.1–0.25 mg/kg/hr** **optional**, selection-dependent (lower end favored in elderly/frail)<br>• Optional: **Lidocaine 1–2 mg/kg/hr** (institutional limits apply; consider total dose ceilings and contraindications) |
| **Emergence** | • Stop dex 10–15 min prior (as tolerated)<br>• Ondansetron **4 mg IV**<br>• Sugammadex PRN |
| **PACU** | • Expected pain **3–6/10**<br>• Ketamine rescue **0.1–0.15 mg/kg IV q10–15 min** (max 3) **when appropriate**<br>• Opioids **only if inadequate response** |

---

# Pathway 3 — Conventional Opioid-Inclusive Anesthesia

| Section | Quick Reference |
|--------|-----------------|
| **Pre-op** | • Acetaminophen **1 g PO**<br>• Celecoxib **400 mg PO**<br>• Dexamethasone **8–10 mg IV**<br>• **Midazolam 1–2 mg IV** (preop anxiolysis; dose-reduce in elderly/frail)<br>• Continue home opioids for chronic users (per institutional guidance) |
| **Induction** | • Midazolam **0.5–1 mg IV** (optional; dose-reduce in elderly/frail)<br>• Propofol **1.5–2 mg/kg**<br>• **Fentanyl 1–2 mcg/kg** OR **Hydromorphone 0.2–0.4 mg** (clinician judgment)<br>• Rocuronium **0.6–1.0 mg/kg** |
| **Maintenance** | • **Sevoflurane 0.8–1.2 MAC** OR **Propofol TIVA**<br>• **Fentanyl 25–50 mcg boluses PRN** for stimulation (institutional practice)<br>• Dexmedetomidine **0.2–0.4 mcg/kg/hr** optional (use caution: bradycardia/hypotension) |
| **Emergence** | • Ondansetron **4 mg IV**<br>• Sugammadex as indicated<br>• **Expect longer emergence** in opioid-exposed patients and in elderly/OSA; maintain a low threshold to delay extubation if somnolent |
| **PACU** | • Expected pain **2–6/10** (variable)<br>• Hydromorphone **0.2 mg IV q10 min PRN** (institutional policy)<br>• **Enhanced respiratory monitoring** (OSA, elderly, high opioid dose) |

---

# Universal Safety Reminders (All Pathways)

- **Propofol induction 1.5–2 mg/kg** is the default primary hypnotic in these pathways (titrate to physiology)  
- **Sevoflurane 0.8–1.2 MAC** OR **Propofol TIVA 75–150 mcg/kg/min** — both valid maintenance strategies  
- **Midazolam** is common for anxiolysis but **dose-reduce in elderly/frail**; avoid oversedation  
- **No gabapentinoids** in routine pathways unless clinically indicated (risk of sedation/delirium/respiratory depression in select populations)  
- **Magnesium:** avoid if **CrCl <30 mL/min**  
- **Dexmedetomidine bradycardia/hypotension:** dose-reduce in elderly/frail; treat symptomatic bradycardia per local practice (e.g., **glycopyrrolate 0.2–0.4 mg IV**) and reduce/stop infusion if recurrent  
- **Ropivacaine total dose:** track cumulative local anesthetic dose; typical max **~3 mg/kg** (institution-dependent)  
- **LAST preparedness:** 20% lipid emulsion must be immediately available where blocks are performed  
- **Maintain MAP ≥65 mmHg** (individualize for CAD/cerebrovascular disease)  
- **Ketamine + BIS:** interpret BIS cautiously after ketamine; correlate clinically / consider raw EEG trends when available  

---

**Print tip:** GitHub → “Print” → Save as PDF → fits on a 2-sided pocket card.
